Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Insight Molecular Diagnostics (IMDX) Asset Utilization Ratio: 2020-2025

Historic Asset Utilization Ratio for Insight Molecular Diagnostics (IMDX) over the last 3 years, with Sep 2025 value amounting to 0.09.

  • Insight Molecular Diagnostics' Asset Utilization Ratio rose 852.71% to 0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09, marking a year-over-year increase of 852.71%. This contributed to the annual value of 0.03 for FY2024, which is 99.13% up from last year.
  • Latest data reveals that Insight Molecular Diagnostics reported Asset Utilization Ratio of 0.09 as of Q3 2025, which was up 21.39% from 0.08 recorded in Q2 2025.
  • In the past 5 years, Insight Molecular Diagnostics' Asset Utilization Ratio registered a high of 0.09 during Q3 2025, and its lowest value of 0.01 during Q3 2024.
  • Over the past 3 years, Insight Molecular Diagnostics' median Asset Utilization Ratio value was 0.02 (recorded in 2023), while the average stood at 0.04.
  • As far as peak fluctuations go, Insight Molecular Diagnostics' Asset Utilization Ratio plummeted by 67.00% in 2022, and later surged by 852.71% in 2025.
  • Over the past 5 years, Insight Molecular Diagnostics' Asset Utilization Ratio (Quarterly) stood at 0.05 in 2021, then tumbled by 67.00% to 0.02 in 2022, then increased by 23.51% to 0.02 in 2023, then soared by 85.98% to 0.04 in 2024, then surged by 852.71% to 0.09 in 2025.
  • Its Asset Utilization Ratio stands at 0.09 for Q3 2025, versus 0.08 for Q2 2025 and 0.08 for Q1 2025.